The most common side effects include abdominal pain, nausea, vomiting, constipation, diarrhea, indigestion, and headache
Get a Quote Tirzepatide 2mg Dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor
Strong healthcare infrastructure, established reimbursement systems, and widespread physician adoption further support market penetration
What This Study Does Not Mean This research feels exciting, but patients need balance
GLP-1s can create a window of lowered food noise and rising self-efficacy for health, said Cook
Semaglutide targets the GLP-1 receptor only, while Tirzepatide targets both GLP-1 and GIP receptors making it a dual-action medication